在人类免疫缺陷病毒合并感染人群中消除丙型肝炎病毒：利用现有的人类免疫缺陷病毒基础设施。
Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.
机构信息
Division of Infectious Diseases, Duke University Medical Center, 315 Trent Drive, Hanes House, Room 181, DUMC Box 102359, Durham, NC 27710, USA.
Department of Medicine, Emory School of Medicine, 49 Jesse Hill Drive Southeast, Atlanta, GA 30303, USA.
出版信息
Infect Dis Clin North Am. 2018 Jun;32(2):407-423. doi: 10.1016/j.idc.2018.02.005.
Abstract
The objective of this review is to consider how existing human immunodeficiency virus (HIV) infrastructure may be leveraged to inform and improve hepatitis C virus (HCV) treatment efforts in the HIV-HCV coinfected population. Current gaps in HCV care relevant to the care continuum are reviewed. Successes in HIV treatment are then applied to the HCV treatment model for coinfected patients. Finally, the authors give examples of HCV treatment strategies for coinfected patients in both domestic and international settings.
摘要
本次综述的目的是探讨现有的人类免疫缺陷病毒 (HIV) 基础设施如何能够为 HIV-HCV 合并感染人群的 HCV 治疗工作提供信息并加以改进。本文回顾了当前 HCV 护理方面与连续护理相关的差距。然后，作者将 HIV 治疗方面的成功经验应用于 HCV 合并感染患者的治疗模式。最后，作者给出了国内外合并感染患者 HCV 治疗策略的实例。
相似文献
1
Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.在人类免疫缺陷病毒合并感染人群中消除丙型肝炎病毒：利用现有的人类免疫缺陷病毒基础设施。
Infect Dis Clin North Am. 2018 Jun;32(2):407-423. doi: 10.1016/j.idc.2018.02.005.
2
Hepatitis C continuum of care: Experience of integrative hepatitis C treatment within a human immunodeficiency virus clinic in Indonesia.丙型肝炎连续护理：印度尼西亚艾滋病毒诊所内综合丙型肝炎治疗的经验。
PLoS One. 2021 Aug 12;16(8):e0256164. doi: 10.1371/journal.pone.0256164. eCollection 2021.
3
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?直接作用抗病毒药物治疗 HIV 感染者的丙型肝炎病毒感染 - “迈向根治”？
J Infect. 2017 Sep;75(3):234-241. doi: 10.1016/j.jinf.2017.05.008. Epub 2017 Jun 2.
4
Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.对HIV/丙型肝炎病毒合并感染患者进行无干扰素的丙型肝炎病毒治疗可导致血清低密度脂蛋白浓度升高。
AIDS Res Hum Retroviruses. 2016 May;32(5):456-62. doi: 10.1089/AID.2015.0170. Epub 2015 Dec 15.
5
HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.HIV 合并感染者与 HCV 单感染者接受 DAA 治疗的 SVR 率相似：是时候结束隔离，将 HIV 患者纳入 HCV 试验了。
Clin Infect Dis. 2015 Oct 1;61(7):1127-34. doi: 10.1093/cid/civ438. Epub 2015 Jun 9.
6
Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.大型综合医疗系统中人类免疫缺陷病毒/丙型肝炎病毒合并感染患者的丙型肝炎治疗接受情况及反应
Int J STD AIDS. 2019 Jun;30(7):689-695. doi: 10.1177/0956462419836520. Epub 2019 May 2.
7
Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?丙型肝炎病毒单感染与 HIV/丙型肝炎病毒合并感染患者的丙型肝炎病毒治疗的药物治疗管理：合并感染真的重要吗？
PLoS One. 2019 Nov 21;14(11):e0225434. doi: 10.1371/journal.pone.0225434. eCollection 2019.
8
Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting.真实世界中直接作用抗病毒药物治疗丙型肝炎单感染与丙型肝炎/人类免疫缺陷病毒合并感染的临床疗效和耐受性比较：社区护理环境下的研究。
Gut Liver. 2018 Nov 15;12(6):694-703. doi: 10.5009/gnl18004.
9
Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis.丙型肝炎病毒获得持续病毒学应答后晚期复发或再感染的风险：一项系统评价和荟萃分析。
Clin Infect Dis. 2016 Mar 15;62(6):683-694. doi: 10.1093/cid/civ948. Epub 2016 Jan 19.
10
Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial.微消除丙型肝炎病毒在人类免疫缺陷病毒合并感染中的应用：随着多中心治疗扩大试验的开展，发病率和患病率呈下降趋势。
Clin Infect Dis. 2021 Oct 5;73(7):e2164-e2172. doi: 10.1093/cid/ciaa1500.
引用本文的文献
1
Disengagement from Care Among People Co-Infected with HIV and HCV: A Scoping Review.艾滋病毒和丙型肝炎病毒合并感染者脱离治疗的情况：一项范围综述
AIDS Behav. 2024 Oct;28(10):3381-3403. doi: 10.1007/s10461-024-04436-6. Epub 2024 Jul 11.
2
Hepatitis C Virus-HIV Coinfection in the United States Among People Who Inject Drugs: Data Needed for Ending Dual Epidemics.美国注射吸毒者中的丙型肝炎病毒与艾滋病病毒合并感染：终结双重疫情所需数据
Public Health Rep. 2023 Jul 22:333549231181348. doi: 10.1177/00333549231181348.
3
Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study.澳大利亚新南威尔士州 HIV 感染者丙型肝炎关怀链评估：一项数据链接研究。
J Viral Hepat. 2022 Apr;29(4):271-279. doi: 10.1111/jvh.13658. Epub 2022 Feb 25.
4
Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs.丙型肝炎护理促进成本：感染 HIV 和丙型肝炎的吸毒者
Drug Alcohol Depend. 2022 Mar 1;232:109265. doi: 10.1016/j.drugalcdep.2022.109265. Epub 2022 Jan 10.
5
Hepatitis C continuum of care: Experience of integrative hepatitis C treatment within a human immunodeficiency virus clinic in Indonesia.丙型肝炎连续护理：印度尼西亚艾滋病毒诊所内综合丙型肝炎治疗的经验。
PLoS One. 2021 Aug 12;16(8):e0256164. doi: 10.1371/journal.pone.0256164. eCollection 2021.
6
Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064).护理促进艾滋病病毒、丙型肝炎和物质使用患者丙型肝炎护理连续过程的进展：一项随机临床试验（CTN-0064）。
Open Forum Infect Dis. 2021 Jun 27;8(8):ofab334. doi: 10.1093/ofid/ofab334. eCollection 2021 Aug.
7
Barriers to hepatitis C direct-acting antiviral therapy among HIV/hepatitis C virus-coinfected persons.HIV/丙型肝炎病毒合并感染人群中丙型肝炎直接作用抗病毒治疗的障碍。
J Gastroenterol Hepatol. 2021 Apr;36(4):1095-1102. doi: 10.1111/jgh.15228. Epub 2020 Sep 8.
8
A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study.现金激励或同伴支持对增加HIV合并吸毒者丙型肝炎病毒治疗率的随机对照试验：CHAMPS研究
Open Forum Infect Dis. 2019 Apr 9;6(4):ofz166. doi: 10.1093/ofid/ofz166. eCollection 2019 Apr.
本文引用的文献
1
Primary Incidence of Hepatitis C Virus Infection Among HIV-Infected Men Who Have Sex With Men in San Diego, 2000-2015.2000 - 2015年圣地亚哥男男性行为者中感染艾滋病毒者丙型肝炎病毒感染的原发性发病率
Open Forum Infect Dis. 2019 Apr 3;6(4):ofz160. doi: 10.1093/ofid/ofz160. eCollection 2019 Apr.
2
Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection.直接作用抗病毒药物改善了艾滋病毒和慢性丙型肝炎病毒感染患者获得治疗和治愈的机会。
Open Forum Infect Dis. 2017 Dec 9;5(1):ofx264. doi: 10.1093/ofid/ofx264. eCollection 2018 Jan.
3
High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic.在城市基层医疗诊所，采用直接作用抗病毒药物治疗的吸毒者，其 HCV 治愈率较高。
Int J Drug Policy. 2017 Sep;47:196-201. doi: 10.1016/j.drugpo.2017.07.021. Epub 2017 Aug 12.
4
Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.大规模改善资源有限环境下的抗逆转录病毒治疗依从性：干预措施与建议探讨
J Int AIDS Soc. 2017 Mar 22;20(1):21371. doi: 10.7448/IAS.20.1.21371. eCollection 2017.
5
High hepatitis C cure rates among black and nonblack human immunodeficiency virus-infected adults in an urban center.城市中心感染人类免疫缺陷病毒的黑人和非黑人成年人中丙型肝炎的高治愈率
Hepatology. 2017 Nov;66(5):1402-1412. doi: 10.1002/hep.29308. Epub 2017 Oct 11.
6
Barriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era.人类免疫缺陷病毒/丙型肝炎病毒合并感染患者启动丙型肝炎病毒治疗的障碍：干扰素时代的经验教训
Open Forum Infect Dis. 2017 Feb 11;4(1):ofx024. doi: 10.1093/ofid/ofx024. eCollection 2017 Winter.
7
Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda.卢旺达接受治疗的艾滋病毒感染者中乙型和丙型肝炎感染的患病率。
BMC Infect Dis. 2017 May 2;17(1):315. doi: 10.1186/s12879-017-2422-9.
8
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.HIV/HCV合并感染及注射吸毒者中的丙型肝炎病毒治愈与再感染
Curr HIV/AIDS Rep. 2017 Jun;14(3):110-121. doi: 10.1007/s11904-017-0358-8.
9
Insights on the Russian HCV Care Cascade: Minimal HCV Treatment for HIV/HCV Co-infected PWID in St. Petersburg.俄罗斯丙型肝炎治疗流程洞察：圣彼得堡艾滋病毒/丙型肝炎合并感染的注射吸毒者的丙型肝炎治疗极少
Hepatol Med Policy. 2016;1. doi: 10.1186/s41124-016-0020-x. Epub 2016 Oct 11.
10
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV.HIV合并感染患者持续病毒学应答后丙型肝炎病毒再感染的危险因素
Clin Infect Dis. 2017 May 1;64(9):1154-1162. doi: 10.1093/cid/cix126.
Zotero 插件